---
Aegon Faces $400 Million H1 2024 Charge Amid Rising U.S. Mortality Rates: What It Means for Investors
By Olivier Sorgho and Dimitri Rhodes
(Multibagger) - Dutch insurer Aegon (NYSE: AEG) has reported a significant charge of approximately $400 million for the first half of 2024 due to increased death-related insurance claims in its primary U.S. market.
Understanding the Charge:
Aegon's Finance Chief, Matt Rider, who is set to retire at the end of this month, explained that the charge is a result of the lingering effects of the COVID-19 pandemic. "We expect that many people had, during the COVID years, not sought medical treatment, and we're seeing the effects of that now, an increased environment for increased mortality," Rider told Multibagger.
Impact on Financial Performance:
The higher mortality rates have adversely impacted Aegon's capital generation and operating results in H1 2024. Despite this, the company’s half-year operating capital generation before holding funding and operating expenses fell only 5% to €588 million ($655 million), surpassing analysts' predictions of €551 million.
Market Reaction:
Following the announcement, Aegon's shares dipped by 6% at 1055 GMT. Analysts from Barclays and J.P. Morgan described the results as mixed, noting that operating profit also fell by 8% to €750 million. Barclays attributed the capital generation beat to one-off events.
Positive Outlook Amid Challenges:
Despite the challenges, Aegon's commercial performance in the U.S. remains robust. This resilience, coupled with the booked charge, has allowed Aegon to revise its second-half operating profit guidance upwards to €800-900 million, according to Rider.
Strategic Focus on the U.S. Market:
Aegon has been strategically divesting its European assets to concentrate on the U.S. market, particularly aiming to make its Transamerica unit a top life insurance and retirement firm for the middle market.
Asset Management and Partnerships:
In its asset management division, Aegon posted net deposits of €8 billion in the Global Platforms and Strategic Partnerships business areas, a significant improvement compared to an outflow last year. The company continues to benefit from its asset management collaboration with ASR Nederland, in which Aegon holds a 30% stake following the sale of its Dutch operations last year.
Financial Conversion:
($1 = 0.8975 euros)
---
Breaking It Down: Why This Matters to You
What’s Happening?
Aegon, a major Dutch insurer, faced a $400 million charge in the first half of 2024 due to increased mortality rates in the U.S., a consequence of people not seeking medical treatment during the COVID-19 pandemic.
Why Should You Care?
- Stock Value Impact: Aegon's stock dropped by 6% following the announcement. If you’re an investor, this might affect the value of your holdings.
- Profit Guidance: Despite the dip, Aegon has increased its profit guidance for the second half of the year, signaling potential future gains.
- Strategic Shifts: Aegon is focusing more on the U.S. market and selling off European assets, which could lead to a more streamlined and potentially more profitable business model.
- Asset Management Strength: The company showed strong performance in asset management, indicating a healthy area of growth.
How Does It Affect Your Finances?
- Investors: Keep an eye on Aegon's stock for potential recovery or further dips.
- Policyholders: Be aware that higher mortality rates could affect the cost and availability of future insurance products.
In essence, while Aegon faces immediate challenges, its strategic refocus and robust asset management performance provide a cautiously optimistic outlook for the future.